TRB Chemedica International

TRB Chemedica International Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von TRB Chemedica International, Route des Jeunes 33bis, Eaux-Vives.

For over 40 years, TRB Chemedica International have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology. TRB Chemedica is a Swiss pharmaceutical company, focus on research & development in specific therapeutic areas, including rheumatology, ophthalmology and neurology.

TRB Chemedica is proud to participate in the Isokinetic Conference 2026, April 18–20 in Athens. Join us at this event fo...
20/03/2026

TRB Chemedica is proud to participate in the Isokinetic Conference 2026, April 18–20 in Athens. Join us at this event for sports medicine professionals to explore evidence-based solutions for musculoskeletal care.

Visit our booth (N°15) to discuss hyaluronic acid therapies that support pain relief, joint function, and recovery pathways. Let’s connect and advance sports medicine together!

Find out more: https://bit.ly/4aUJMBY

18/03/2026

🎥 Webinar Replay Now Live!
Ready to get back in the game after arthroscopy? Discover proven strategies for a confident return to sport and work with insights from Prof. Alkis Kalliakmanis. Watch the replay and empower your recovery!
https://pulse.ly/agjanvgtfn

TRB is proud to participate in the Isokinetic Conference 2026, April 18–20 in Athens. Join us at this event for sports m...
16/03/2026

TRB is proud to participate in the Isokinetic Conference 2026, April 18–20 in Athens. Join us at this event for sports medicine professionals to explore evidence-based solutions for musculoskeletal care.

Visit our booth (N°15) to discuss hyaluronic acid therapies that support pain relief, joint function, and recovery pathways. Let’s connect and advance sports medicine together!
https://pulse.ly/nxmn6k7sz0

👁️ World Glaucoma DayAt TRB Chemedica, we offer a complete range of preservative-free antiglaucoma eye drops, complement...
12/03/2026

👁️ World Glaucoma Day

At TRB Chemedica, we offer a complete range of preservative-free antiglaucoma eye drops, complemented by ocular surface solutions such as VISMED® and RELYS®, used to relieve dryness caused by antiglaucoma therapy. Because treating glaucoma also means protecting the ocular surface in the long term.
https://bit.ly/4sHOB8R

26/02/2026

VISMED® unveils a fresh new look.
Trusted for 25 years, VISMED® is unveiling a modern and refreshed packaging design. Discover the details behind this next chapter.
https://pulse.ly/zztqfnoaww

Replay available 🎥 | Advancing Small Joints Osteoarthritis Care (TMJ focus). If you missed our recent session, you can n...
23/02/2026

Replay available 🎥 | Advancing Small Joints Osteoarthritis Care (TMJ focus). If you missed our recent session, you can now watch the replay and hear leading experts discuss practical approaches to temporo-mandibular joint (TMJ) osteoarthritis.
Watch the replay here: https://pulse.ly/qu62dzau8n

Join us on Monday, March 23rd, from 6:00 PM to 7:00 PM (CET) for an expert-led TRB Academy session with Dr. Henning Ott....
08/02/2026

Join us on Monday, March 23rd, from 6:00 PM to 7:00 PM (CET) for an expert-led TRB Academy session with Dr. Henning Ott. https://bit.ly/4tfzvs9
📌Topic: Balancing Benefits and Risks: A Critical Evaluation of Steroid and Hyaluronic-Acid Injections for Tendinopathy. Explore the key differences between steroid and hyaluronic-acid injections and how to weigh efficacy, safety, and practical considerations to support patient care and prevent long-terms complications.

19/01/2026

Early registration for the TRB Ocular Surface Academy 2026 is now open! Join this live-streamed event to connect with leading experts and explore the latest advancements in ocular surface health. Secure your free spot today https://bit.ly/49IaxJ7

18/12/2025
18/11/2025

The replay of our TRB Academy webinar held on June 30th, “Tailoring Injectable Treatments for Tendinopathies: From Evidence to Clinical Practice,” is now available. 👉Watch the replay https://bit.ly/4pdfxeG

Presented by Prof. Anja Hirschmüller, the session offer clear, evidence-based guidance on injectable treatements for tendinopathy management. If you missed the live session, you can now watch the full presentation and Q&A.

07/11/2025

Join us on Monday, December 1, from 6:00 PM to 7:00 PM (CET) for an expert-led TRB Academy session with Prof. Alkis Kalliakmanis.
Register now: https://bit.ly/3XhPHuc

📌 Topic: Optimizing Recovery After Arthroscopy: Tailored Pathways to Sport and Work Reintegration

Explore evidence-based strategies and personalized approaches to optimize post-arthroscopy recovery and support a safe, efficient return to sport and work.

Don’t miss this opportunity to learn more about rehabilitation approaches.

10/10/2025

This coming , how can we truly empower mobility, ease pain, and restore quality of life for millions worldwide?

At TRB Chemedica we believe the answer lies in progress, built on empathy and science — because everyone deserves the freedom to move without limits.
To everyone affected: You are not alone. Progress is possible. Together, we move forward. Learn more about our dedicated efforts in the field of arthritis treatment. https://bit.ly/4oeA3LQ

Adresse

Route Des Jeunes 33bis
Eaux-Vives
1227

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TRB Chemedica International erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Notre histoire

We are a market-leading pharma and biotechnology company, based in Switzerland and operating around the world.

Founded by Dr Guido Di Napoli in 1980, TRB Chemedica followed a gradual business evolution and expansion through the development of a worldwide network of subsidiaries and distributors.

For over 30 years, we have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology.

Our medium-sized company, supported by an exclusive network of affiliates, agents and partners, makes us efficient and responsive in the market, with the ability to develop customized solutions for patients and partners in our three focus areas that are hyluronic acid diacerein and GM1 ganglioside.